• About us
• Contact

Advertisement

Product › Details

tranylcypromine (INN)

	Next higher product group	antidepressant
	Status	1990-09-01 post-marketing monit existent
	Status	1998-01-01 sales existent

Record changed: 2023-07-10

Advertisement

More documents for antidepressant

• [1] H. Lundbeck A/S. (9/20/25). "Press Release: Otsuka and Lundbeck Receive Complete Response Letter from U.S. FDA for sNDA of Rexulti (Brexpiprazole) in Combination with Sertraline for the Treatment of Adults with PTSD". Valby....
• [2] Draig Therapeutics Ltd.. (6/18/25). "Press Release: Draig Therapeutics Launches with $140 Million (£107 Million) Total Investment to Advance its Portfolio of Next-Generation Therapies for Major Neuropsychiatric Disorders". Cardiff....
• [3] Elkedonia S.A.S.. (6/11/25). "Press Release: Elkedonia Closes EUR 11 Million Seed Round to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders". Strasbourg & Charleroi....
• [4] Angelini Ventures S.p.A.. (6/11/25). "Press Release: Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders". Rome....
• [5] Atai Life Sciences N.V.. (6/2/25). "Press Release: Atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies". New York, NY, Berlin & Oxford....
• [6] AbbVie Inc.. (10/24/24). "Press Release: AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions". North Chicago, IL & Budapest....
• [7] Alto Neuroscience Inc.. (10/14/21). "Press Release: Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing". Los Altos, CA....
• [8] HMNC Holding GmbH. (7/28/21). "Press Release: HMNC Brain Health Raises EUR 9 Million". Munich....
• [9] Compass Pathways plc. (7/5/21). "Press Release: Compass Pathways Joins Forces with King’s College London and South London and Maudsley NHS Foundation Trust to Accelerate Psychedelic Research and Develop New Models of Mental Health Care in the UK". Londo...
• [10] Compass Pathways plc. (4/30/21). "Press Release: Compass Pathways Announces Pricing of Public Offering". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.